Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
Provided By GlobeNewswire
Last update: Jun 3, 2025
BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the appointment of Maha Radhakrishnan, M.D., to its Board of Directors.
Read more at globenewswire.comNASDAQ:TRDA (12/22/2025, 3:44:09 PM)
10.56
-0.42 (-3.83%)
Find more stocks in the Stock Screener
